Terms: = Head and neck cancer AND ABL1, p150, 25, ENSG00000097007, P00519, v-abl, bcr/abl, JTK7, c-ABL, ABL, BCR-ABL AND Clinical Outcome
224 results:
1. Tumor volume instead of recurrent T category predicts clinical outcome of patients with locally recurrent nasopharyngeal carcinoma salvaged by carbon ion radiation therapy.
Hu J; Huang Q; Hu W; Liang F; Gao J; Yang J; Qiu X; Zhang H; Zhang G; Lu JJ; Kong L
Oral Oncol; 2024 Apr; 151():106683. PubMed ID: 38387259
[TBL] [Abstract] [Full Text] [Related]
2. head and neck continued: a retrospective analysis of neck dissections from a New Zealand oral and maxillofacial surgery unit.
Simpson EOY; Luo A; Mckenzie J; Maharaj MM; Singh T
N Z Med J; 2023 Oct; 136(1583):21-29. PubMed ID: 37797252
[TBL] [Abstract] [Full Text] [Related]
3. clinical and imaging features of interstitial lung disease in cancer patients treated with trastuzumab deruxtecan.
Baba T; Kusumoto M; Kato T; Kurihara Y; Sasaki S; Oikado K; Saito Y; Endo M; Fujiwara Y; Kenmotsu H; Sata M; Takano T; Kato K; Hirata K; Katagiri T; Saito H; Kuwano K
Int J Clin Oncol; 2023 Dec; 28(12):1585-1596. PubMed ID: 37787866
[TBL] [Abstract] [Full Text] [Related]
4. Role of gene sequencing in classifying struma ovarii: BRAF p.G469A mutation and TERT promoter alterations favour malignant struma ovarii.
Neyrand S; Trecourt A; Lopez J; Just PA; Descotes F; Borson-Chazot F; Ray-Coquard I; Decaussin-Petrucci M; Devouassoux-Shisheboran M
Histopathology; 2024 Jan; 84(2):291-300. PubMed ID: 37771077
[TBL] [Abstract] [Full Text] [Related]
5. Novel tetrahydrocurcumin integrated mucoadhesive nanocomposite κ-carrageenan/xanthan gum sponges: a strategy for effective local treatment of oral cancerous and precancerous lesions.
Elbanna SA; Ebada HMK; Abdallah OY; Essawy MM; Abdelhamid HM; Barakat HS
Drug Deliv; 2023 Dec; 30(1):2254530. PubMed ID: 37668361
[TBL] [Abstract] [Full Text] [Related]
6. Long-term prognostic analysis of children and adolescents with differentiated thyroid carcinoma based on therapeutic response to initial radioiodine therapy.
Wang C; Lu G; Li Y; Liu X; Wang G; Lu C; Li J; Luo Q; Zhang Q; Sun M; Wang X; Wang R
Front Endocrinol (Lausanne); 2023; 14():1217092. PubMed ID: 37600705
[TBL] [Abstract] [Full Text] [Related]
7. clinical outcome of endoscopic-assisted transoral surgery for superficial cancer of pharyngo-esophageal junction.
Furue Y; Hori K; Tomioka T; Fujii S; Okano W; Shinozaki T; Kadota T; Yoda Y; Hayashi R; Yano T
Head Neck; 2023 Aug; 45(8):2098-2107. PubMed ID: 37350231
[TBL] [Abstract] [Full Text] [Related]
8. PYloroplasty versus No Intervention in GAstric REmnant REconstruction after Oesophagectomy: study protocol for the PYNI-GAREREO phase III randomized controlled trial.
Okada N; Kinoshita Y; Nishihara S; Kurotaki T; Sato A; Kimura K; Kushiya H; Umemoto K; Furukawa S; Yamabuki T; Takada M; Kato K; Ambo Y; Nakamura F
Trials; 2023 Jun; 24(1):412. PubMed ID: 37337238
[TBL] [Abstract] [Full Text] [Related]
9. Recurrence and mortality rate in an Italian multi-center case series of parathyroid atypical adenomas and carcinomas.
Barale M; Nervo A; Craparo A; Pusterla A; Retta F; Maiorino F; Castellano E; Piovesan A; Gianotti L; Borretta G; Procopio M; Arvat E
Front Endocrinol (Lausanne); 2023; 14():1158474. PubMed ID: 37223026
[TBL] [Abstract] [Full Text] [Related]
10. Real-world Data of Palliative First-line Checkpoint Inhibitor Therapy for head and neck cancer.
Wagner SM; Magnes T; Melchardt T; Kiem D; Weiss L; Neureiter D; Wagner C; Aretin MB; Nemec S; Gamerith G; Pall G; Greil R; Fuereder T
Anticancer Res; 2023 Mar; 43(3):1273-1282. PubMed ID: 36854497
[TBL] [Abstract] [Full Text] [Related]
11. clinical outcome and prognostic factors in adenoid cystic carcinoma of the external auditory canal: proposal for a refined T-stage classification system.
Lee JY; Cho YS
Eur Arch Otorhinolaryngol; 2023 Aug; 280(8):3625-3633. PubMed ID: 36781438
[TBL] [Abstract] [Full Text] [Related]
12. Positive
Huang S; Qi M; Tian T; Dai H; Tang Y; Huang R
Front Endocrinol (Lausanne); 2022; 13():959089. PubMed ID: 36407316
[TBL] [Abstract] [Full Text] [Related]
13. A 25-gene panel predicting the benefits of immunotherapy in head and neck squamous cell carcinoma.
Huang Y; Liao J; Liang F; Lin P; Wu S; Ye Y; Gao M; Chen R; Zeng H; Yin X; Jiang Y; Ouyang N; Han P; Huang X
Int Immunopharmacol; 2022 Sep; 110():108846. PubMed ID: 35816946
[TBL] [Abstract] [Full Text] [Related]
14. Potential Impact of Body Mass Index on the clinical outcome of Papillary Thyroid cancer After High-Dose Radioactive Iodine Therapy.
Cao J; Zhu X; Sun Y; Li X; Yun C; Zhang W
Front Endocrinol (Lausanne); 2022; 13():870530. PubMed ID: 35721759
[TBL] [Abstract] [Full Text] [Related]
15. Cross-talk between the microbiome and chronic inflammation in esophageal cancer: potential driver of oncogenesis.
Sharma T; Gupta A; Chauhan R; Bhat AA; Nisar S; Hashem S; Akhtar S; Ahmad A; Haris M; Singh M; Uddin S
Cancer Metastasis Rev; 2022 Jun; 41(2):281-299. PubMed ID: 35511379
[TBL] [Abstract] [Full Text] [Related]
16. The Prognostic Significance of p16 and its Role as a Surrogate Marker for Human Papilloma Virus in Oral Squamous Cell Carcinoma: An Analysis of 281 Cases.
Doll C; Steffen C; Beck-Broichsitter B; Richter M; Neumann K; Pohrt A; Lohneis P; Lehmann A; Heiland M; Stromberger C; Coordes A; Johrens K; Raguse JD
Anticancer Res; 2022 May; 42(5):2405-2413. PubMed ID: 35489745
[TBL] [Abstract] [Full Text] [Related]
17.
Tsamadou C; Engelhardt D; Platzbecker U; Sala E; Valerius T; Wagner-Drouet E; Wulf G; Kröger N; Murawski N; Einsele H; Schaefer-Eckart K; Freitag S; Casper J; Kaufmann M; Dürholt M; Hertenstein B; Klein S; Ringhoffer M; Frank S; Neuchel C; Schrezenmeier H; Mytilineos J; Fuerst D
Front Immunol; 2021; 12():771449. PubMed ID: 34970261
[TBL] [Abstract] [Full Text] [Related]
18. Impact of radiogenomics in esophageal cancer on clinical outcomes: A pilot study.
Brancato V; Garbino N; Mannelli L; Aiello M; Salvatore M; Franzese M; Cavaliere C
World J Gastroenterol; 2021 Sep; 27(36):6110-6127. PubMed ID: 34629823
[TBL] [Abstract] [Full Text] [Related]
19. Impact of prior cancer on the overall survival of patients with nasopharyngeal carcinoma.
Wang X; Wang Z; Chen Y; Lin Q; Chen H; Lin Y; Lu L; Zheng P; Chen X
Am J Otolaryngol; 2022; 43(1):103235. PubMed ID: 34563802
[TBL] [Abstract] [Full Text] [Related]
20. HO-1 in lymph node metastasis predicted overall survival in patients with esophageal squamous cell carcinoma receiving neoadjuvant chemoradiation therapy.
Akaishi R; Fujishima F; Ishida H; Tsunokake J; Yamauchi T; Gokon Y; Ueki S; Fukutomi T; Okamoto H; Takaya K; Sato C; Taniyama Y; Nakamura T; Nakaya N; Kamei T; Sasano H
Cancer Rep (Hoboken); 2022 Mar; 5(3):e1477. PubMed ID: 34264023
[TBL] [Abstract] [Full Text] [Related]
[Next]
